Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, announced that CEO Brian Markison will present at the 2025 Truist Securities MedTech Conference on Tuesday, June 17 at 8:40 a.m. ET. The presentation will be accessible via live webcast through the Investors section of Lantheus's website at www.lantheus.com. A replay will remain available on the company's website for a minimum of 30 days after the live presentation.
Lantheus Holdings (NASDAQ: LNTH), un'azienda leader nel settore dei radiofarmaci, ha annunciato che il CEO Brian Markison presenterà alla Truist Securities MedTech Conference 2025 martedì 17 giugno alle 8:40 ET. La presentazione sarà disponibile in diretta streaming nella sezione Investitori del sito web di Lantheus all'indirizzo www.lantheus.com. Una registrazione resterà accessibile sul sito dell'azienda per almeno 30 giorni dopo la trasmissione dal vivo.
Lantheus Holdings (NASDAQ: LNTH), una empresa líder en radiofármacos, anunció que el CEO Brian Markison presentará en la Conferencia MedTech de Truist Securities 2025 el martes 17 de junio a las 8:40 a.m. ET. La presentación estará disponible en webcast en vivo a través de la sección de Inversores en el sitio web de Lantheus en www.lantheus.com. Una repetición estará disponible en el sitio web de la empresa durante al menos 30 días después de la presentación en vivo.
라네더스 홀딩스(NASDAQ: LNTH), 선도적인 방사성 의약품 회사는 CEO 브라이언 마키슨이 2025년 6월 17일 화요일 오전 8시 40분(동부시간)에 열리는 Truist Securities MedTech 컨퍼런스에서 발표할 예정이라고 발표했습니다. 발표는 라네더스 웹사이트(www.lantheus.com)의 투자자 섹션을 통해 실시간 웹캐스트로 시청할 수 있습니다. 생중계 후 최소 30일 동안 회사 웹사이트에서 다시보기 서비스를 제공합니다.
Lantheus Holdings (NASDAQ : LNTH), une entreprise leader dans le domaine des radiopharmaceutiques, a annoncé que le PDG Brian Markison présentera lors de la conférence Truist Securities MedTech 2025, le mardi 17 juin à 8h40 ET. La présentation sera accessible en webcast en direct via la section Investisseurs du site web de Lantheus à l'adresse www.lantheus.com. Une rediffusion restera disponible sur le site de l'entreprise pendant au moins 30 jours après la présentation en direct.
Lantheus Holdings (NASDAQ: LNTH), ein führendes Radiopharmaunternehmen, gab bekannt, dass CEO Brian Markison am Dienstag, den 17. Juni 2025, um 8:40 Uhr ET auf der Truist Securities MedTech Konferenz präsentieren wird. Die Präsentation wird live per Webcast über den Investor-Bereich der Lantheus-Website unter www.lantheus.com zugänglich sein. Eine Aufzeichnung wird für mindestens 30 Tage nach der Live-Präsentation auf der Unternehmenswebsite verfügbar bleiben.
Positive
None.
Negative
None.
BEDFORD, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the 2025 Truist Securities MedTech Conference at 8:40 a.m. ET on Tuesday, June 17.
To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Sweden and Switzerland, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com.
Contacts: Mark Kinarney Vice President, Investor Relations 978-671-8842 ir@lantheus.com
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, to receive support.
